文献速递产科母胎医学

脐静脉血流评估在预测胎儿生长速度和不良结局中的作用:一项前瞻性观察性队列研究

The role of umbilical vein blood flow assessment in the prediction of fetal growth velocity and adverse outcome: a prospective observational cohort study.
PubMed 文献 · Am J Obstet Gynecol · 2025-01-04

该前瞻性多中心观察性队列研究纳入64例小于胎龄儿和58例胎儿生长受限,评估脐静脉血流与胎儿生长速度的关系及其预测不良围产结局和医源性早产的能力。脐静脉血流与胎儿生长速度正相关(r=0.46,P<.001),两者均为医源性早产和不良围产结局的独立预测因素。

要点

  • 小于胎龄儿与参考范围相比,胎儿生长速度和脐静脉血流均显著降低(P<.001)。
  • 胎儿生长受限较小为胎龄儿脐静脉血流更低(P<.001),脐静脉血流与胎儿生长速度正相关(r=0.46,P<.001)。
  • 脐静脉血流≤0.65中位数倍数(aOR 3.5;95%CI 1.0-11.8)和胎儿生长速度≤0.63中位数倍数(aOR 3.0,95%CI 1.2-7.9)与不良围产结局相关。

核心结论

  • 脐静脉血流可能有助于识别胎儿生长受限并预测后续生物测量评估中的胎儿生长。
  • 脐静脉血流与胎儿生长速度显著相关,两者均为小胎儿人群中医源性早产和不良围产结局的独立预测因素,无论是否符合Delphi共识标准。
  • 这些结果支持未来进一步研究该参数在疑似胎儿生长受限胎儿中的预测价值。

研究设计与样本

  • 前瞻性多中心观察性队列研究,纳入诊断为小于胎龄儿或胎儿生长受限的孕妇,进行胎儿生物测量和多普勒评估(包括脐静脉血流测量)。
  • 胎儿生长速度由两次连续超声评估计算的估计胎儿体重之差得出,妊娠随访至分娩。
  • 研究人群包括64例小于胎龄儿和58例胎儿生长受限。

主要发现

  • 与参考范围相比,小于胎龄儿胎儿生长速度和脐静脉血流显著降低(P<.001)。
  • 与小于胎龄儿相比,胎儿生长受限胎儿脐静脉血流更低(P<.001),校正估计胎儿体重和腹围的脐静脉血流更低(P<.01和P<.001),胎儿生长速度更低(P<.001)。
  • 胎儿生长速度与脐静脉血流呈正相关(r=0.46,P<.001)。
  • 校正胎儿生长受限诊断后,脐静脉血流≤0.65中位数倍数(aOR 3.5;95%CI 1.0-11.8)和胎儿生长速度≤0.63中位数倍数(aOR 3.0,95%CI 1.2-7.9)与不良围产结局相关。
  • 校正胎儿生长受限诊断后,脐静脉血流≤0.60中位数倍数(aOR 5.2,95%CI 1.7-15.9)和胎儿生长速度≤0.63中位数倍数(aOR 3.6,95%CI 1.1-12.6)为医源性早产的显著预测因素。

关键数值与推荐

  • 脐静脉血流≤0.65中位数倍数预测不良围产结局的aOR为3.5(95%CI 1.0-11.8)。
  • 胎儿生长速度≤0.63中位数倍数预测不良围产结局的aOR为3.0(95%CI 1.2-7.9)。
  • 脐静脉血流≤0.60中位数倍数预测医源性早产的aOR为5.2(95%CI 1.7-15.9)。
  • 胎儿生长速度≤0.63中位数倍数预测医源性早产的aOR为3.6(95%CI 1.1-12.6)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Identifying fetal growth restriction and distinguishing it from a constitutionally small fetus can be challenging. The umbilical vein blood flow is a surrogate parameter of the amount of oxygen and nutrients delivered to the fetus, providing valuable insights about the function of the placenta. Nevertheless, currently, this parameter is not used in the diagnosis and management of fetal growth restriction. OBJECTIVE: To evaluate the umbilical vein blood flow and fetal growth velocity in small for gestational age fetuses and in fetal growth restriction, and to evaluate their capacity to predict adverse perinatal outcome and iatrogenic preterm birth. Secondly, to assess the correlation between umbilical vein blood flow and fetal growth velocity. STUDY DESIGN: This was a prospective multicentric observational cohort study of women with a diagnosis of small for gestational age or fetal growth restriction in which fetal biometry and Doppler assessment, including umbilical vein blood flow measurement, were performed. The fetal growth velocity was derived from the difference between the estimated fetal weight calculated in 2 consecutive sonographic evaluations. The pregnancies were followed until delivery. Between-group differences were evaluated, and Pearson or Spearman correlation coefficients were reported to assess the relationship between variables of interest. Optimal cutoffs on the resulting receiver operating characteristic curve were determined and used to predict the outcomes of interest. Simple and multiple logistic regression models were estimated using umbilical vein blood flow and fetal growth velocity to predict adverse perinatal outcomes and iatrogenic preterm birth. RESULTS: The study population included 64 small for gestational age and 58 growth restricted fetuses. When compared to reference ranges, small for gestational age fetuses had significantly lower fetal growth velocity and umbilical vein blood flow (P<.001). When compared to small for gestational age, fetuses with growth restriction had lower umbilical vein blood flow (P<.001), umbilical vein blood flow corrected for estimated fetal weight and abdominal circumference (P<.01 and P<.001), and fetal growth velocity (P<.001). Fetal growth velocity was positively correlated with umbilical vein blood flow (r=0.46, P<.001). The multivariable logistic regression analyses showed that, after adjusting for diagnosis of fetal growth restriction, umbilical vein blood flow ≤0.65 multiple of the median (adjusted odds ratio [aOR] 3.5; 95% confidence interval [CI] 1.0-11.8) and fetal growth velocity ≤0.63 multiple of the median (adjusted odds ratio 3.0, 95% CI 1.2-7.9) were associated with adverse perinatal outcome. Furthermore, when accounting for fetal growth restriction diagnosis, umbilical vein blood flow ≤0.60 multiple of the median (adjusted odds ratio 5.2, 95% CI 1.7-15.9), and fetal growth velocity ≤0.63 multiple of the median (adjusted odds ratio 3.6, 95% CI 1.1-12.6) were significant predictors of iatrogenic preterm birth. CONCLUSION: Umbilical vein blood flow could play a role to identify fetuses with fetal growth restriction and to predict fetal growth at the subsequent biometric evaluation. We found a significant correlation between umbilical vein blood flow and fetal growth. Umbilical vein blood flow and fetal growth velocity are independent predictors of iatrogenic preterm birth and adverse perinatal outcome in a population of small fetuses, regardless of the Delphi consensus criteria. These results support future study on the predictive value of this parameter in fetuses with a suspected fetal growth restriction.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Farsetti D, Barbieri M, Magni E, et al. The role of umbilical vein blood flow assessment in the prediction of fetal growth velocity and adverse outcome: a prospective observational cohort study. Am J Obstet Gynecol. 2025. PMID: 39756605. doi:10.1016/j.ajog.2025.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。